AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
SOLUBLE MEDIATORS AND THE INTERACTION OF DRUGS IN IBD
Authors: RASKMADSEN J
Citation: J. Raskmadsen, SOLUBLE MEDIATORS AND THE INTERACTION OF DRUGS IN IBD, Medicamentos de actualidad, 34(1), 1998, pp. 45-63
FROM BASIC SCIENCE TO FUTURE MEDICAL OPTIONS FOR TREATMENT OF ULCERATIVE-COLITIS
Authors: RASKMADSEN J
Citation: J. Raskmadsen, FROM BASIC SCIENCE TO FUTURE MEDICAL OPTIONS FOR TREATMENT OF ULCERATIVE-COLITIS, European journal of gastroenterology & hepatology, 9(9), 1997, pp. 864-871
NITRIC-OXIDE IN COLONIC INFLAMMATION - PROINFLAMMATORY MEDIATOR OR PROTECTIVE FACTOR
Authors: PERNER A HILLINGSO J NORDGAARD I MATZEN P HOJGAARD L RASKMADSEN J
Citation: A. Perner et al., NITRIC-OXIDE IN COLONIC INFLAMMATION - PROINFLAMMATORY MEDIATOR OR PROTECTIVE FACTOR, Gut, 41, 1997, pp. 17-17
INFLAMMATORY MEDIATORS IN COLLAGENOUS COLITIS
Authors: BOHR J TYSK C DANIELSSON D JARNEROT G BUKHAVE K RASKMADSEN J
Citation: J. Bohr et al., INFLAMMATORY MEDIATORS IN COLLAGENOUS COLITIS, Gut, 41, 1997, pp. 116-116
REAPPRAISAL OF BICARBONATE SECRETION BY THE HUMAN ESOPHAGUS
Authors: MERTZNIELSEN A HILLINGSO J BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., REAPPRAISAL OF BICARBONATE SECRETION BY THE HUMAN ESOPHAGUS, Gut, 40(5), 1997, pp. 582-586
GREATLY INCREASED MUCOSAL NITRIC-OXIDE (NO) PRODUCTION INPATIENTS WITH COLLAGENOUS COLITIS (CC)
Authors: HILLINGSO J NORDGAARDANDERSEN I MUNKHOLM P RUMESSEN J MATZEN P HOJGAARD L RASKMADSEN J
Citation: J. Hillingso et al., GREATLY INCREASED MUCOSAL NITRIC-OXIDE (NO) PRODUCTION INPATIENTS WITH COLLAGENOUS COLITIS (CC), Gastroenterology, 112(4), 1997, pp. 995-995
NEUROPEPTIDES IN THE RECTAL MUCOSA OF PATIENTS WITH ULCERATIVE-COLITIS - A RATIONALE FOR TREATMENT UNFULFILLED
Authors: HILLINGSO J SCHMIDT P HANSEN BF BUKHAVE K HOLST JJ RASKMADSEN J
Citation: J. Hillingso et al., NEUROPEPTIDES IN THE RECTAL MUCOSA OF PATIENTS WITH ULCERATIVE-COLITIS - A RATIONALE FOR TREATMENT UNFULFILLED, Gastroenterology, 112(4), 1997, pp. 996-996
NITRIC-OXIDE (NO) DETERMINED BY CHEMILUMINESCENCE DURING STEADY-STATEPERFUSION OF COLON WITH ARGON IN ULCERATIVE-COLITIS (UC) AND CROHNS-COLITIS (CC) PATIENTS
Authors: HILLINGSO J MUNKHOLM P RUMESSEN J BENDTSEN F MATZEN P HOJGAARD L RASKMADSEN J
Citation: J. Hillingso et al., NITRIC-OXIDE (NO) DETERMINED BY CHEMILUMINESCENCE DURING STEADY-STATEPERFUSION OF COLON WITH ARGON IN ULCERATIVE-COLITIS (UC) AND CROHNS-COLITIS (CC) PATIENTS, Gastroenterology, 112(4), 1997, pp. 996-996
A TRIAL OF ZILEUTON VERSUS MESALAZINE OR PLACEBO IN THE MAINTENANCE OF REMISSION OF ULCERATIVE-COLITIS
Authors: HAWKEY CJ DUBE LM ROUNTREE LV LINNEN PJ LANCASTER JF KREJS GJ GANGL A VANTRAPPEN G BARBIER F POLESKI M MARTIN F SAIBIL F RASKMADSEN J LAURITSEN K BARBIER JP RAMBAUD JC COUTURIER D CASPARY WF GOEBELL H DOELLE W STROHMEYER G SWOBODNIK W RAEDLER A SKANDALIS N VANDEVENTER SJH SNEL P WRIGHT JP GESSULL MA GONZALES F OBRADOR A HALTER F KAYASSEH L OMORAIN C REES WO
Citation: Cj. Hawkey et al., A TRIAL OF ZILEUTON VERSUS MESALAZINE OR PLACEBO IN THE MAINTENANCE OF REMISSION OF ULCERATIVE-COLITIS, Gastroenterology, 112(3), 1997, pp. 718-724
CONTROVERSIAL ASPECTS IN THE PATHOPHYSIOLOGY OF DUODENAL-ULCER - IN RESPONSE
Authors: MERTZNIELSEN A HILLINGSO J FROKIAER H BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., CONTROVERSIAL ASPECTS IN THE PATHOPHYSIOLOGY OF DUODENAL-ULCER - IN RESPONSE, Scandinavian journal of gastroenterology, 31(8), 1996, pp. 831-832
DANISH GASTROENTEROLOGY 1971-1996 - FOREWORD
Authors: RASKMADSEN J
Citation: J. Raskmadsen, DANISH GASTROENTEROLOGY 1971-1996 - FOREWORD, Scandinavian journal of gastroenterology, 31, 1996, pp. 5-5
MEDIATORS OF INFLAMMATION IN CHRONIC INFLAMMATORY BOWEL-DISEASE
Authors: NIELSEN OH RASKMADSEN J
Citation: Oh. Nielsen et J. Raskmadsen, MEDIATORS OF INFLAMMATION IN CHRONIC INFLAMMATORY BOWEL-DISEASE, Scandinavian journal of gastroenterology, 31, 1996, pp. 149-159
GASTRIC BICARBONATE SECRETION AND RELEASE OF PROSTAGLANDIN E(2) ARE INCREASED IN DUODENAL-ULCER PATIENTS BUT NOT IN HELICOBACTER PYLORI-POSITIVE HEALTHY-SUBJECTS
Authors: MERTZNIELSEN A HILLINGSO J FROKLAER H BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., GASTRIC BICARBONATE SECRETION AND RELEASE OF PROSTAGLANDIN E(2) ARE INCREASED IN DUODENAL-ULCER PATIENTS BUT NOT IN HELICOBACTER PYLORI-POSITIVE HEALTHY-SUBJECTS, Scandinavian journal of gastroenterology, 31(1), 1996, pp. 38-43
OMEPRAZOLE PROMOTES PROXIMAL DUODENAL MUCOSAL BICARBONATE SECRETION IN HUMANS
Authors: MERTZNIELSEN A HILLINGSO J BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., OMEPRAZOLE PROMOTES PROXIMAL DUODENAL MUCOSAL BICARBONATE SECRETION IN HUMANS, Gut, 38(1), 1996, pp. 6-10
SELECTIVE BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE-DOSE OF THE FPL 64170XX 0.5-PERCENT ENEMA IN ACTIVE ULCERATIVE-COLITIS
Authors: KJELDSEN J LAURSEN LS HILLINGSO J MERTZNIELSEN A BUKHAVE K RASKMADSEN J LAURITSEN K
Citation: J. Kjeldsen et al., SELECTIVE BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE-DOSE OF THE FPL 64170XX 0.5-PERCENT ENEMA IN ACTIVE ULCERATIVE-COLITIS, Pharmacology & toxicology, 77(6), 1995, pp. 371-376
INDOMETHACIN DECREASES GASTRODUODENAL MUCOSAL BICARBONATE SECRETION IN HUMANS
Authors: MERTZNIELSEN A HILLINGSO J BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., INDOMETHACIN DECREASES GASTRODUODENAL MUCOSAL BICARBONATE SECRETION IN HUMANS, Scandinavian journal of gastroenterology, 30(12), 1995, pp. 1160-1165
MISOPROSTOL INHIBITS GASTRIC-MUCOSAL RELEASE OF ENDOGENOUS PROSTAGLANDIN E(2) AND THROMBOXANE B-2 IN HEALTHY-VOLUNTEERS
Authors: MERTZNIELSEN A ESKEROD O BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., MISOPROSTOL INHIBITS GASTRIC-MUCOSAL RELEASE OF ENDOGENOUS PROSTAGLANDIN E(2) AND THROMBOXANE B-2 IN HEALTHY-VOLUNTEERS, Gut, 36(4), 1995, pp. 511-515
MUSCARINIC M(1) RECEPTOR INHIBITION REDUCES GASTRODUODENAL BICARBONATE SECRETION AND PROMOTES GASTRIC PROSTAGLANDIN E(2) SYNTHESIS IN HEALTHY-VOLUNTEERS
Authors: MERTZNIELSEN A HILLINGSO J ESKEROD O BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., MUSCARINIC M(1) RECEPTOR INHIBITION REDUCES GASTRODUODENAL BICARBONATE SECRETION AND PROMOTES GASTRIC PROSTAGLANDIN E(2) SYNTHESIS IN HEALTHY-VOLUNTEERS, Gut, 36(4), 1995, pp. 528-533
HELICOBACTER-PYLORI DOES NOT INFLUENCE GASTRODUODENAL BICARBONATE SECRETION AND LUMINAL RELEASE OF PROSTAGLANDIN-E2 IN HUMANS
Authors: MERTZNIELSEN A HILLINGS J BUKHAVE K RASKMADSEN J
Citation: A. Mertznielsen et al., HELICOBACTER-PYLORI DOES NOT INFLUENCE GASTRODUODENAL BICARBONATE SECRETION AND LUMINAL RELEASE OF PROSTAGLANDIN-E2 IN HUMANS, Gastroenterology, 108(4), 1995, pp. 165-165
IN-VIVO BICARBONATE SECRETION BY HUMAN ESOPHAGUS - EFFECT OF OMEPRAZOLE AND RANITIDINE
Authors: MERTZNIELSEN A HILLINGSO J RASKMADSEN J
Citation: A. Mertznielsen et al., IN-VIVO BICARBONATE SECRETION BY HUMAN ESOPHAGUS - EFFECT OF OMEPRAZOLE AND RANITIDINE, Gastroenterology, 108(4), 1995, pp. 166-166
BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE ORAL DOSE OF MK-0591 IN ACTIVE ULCERATIVE-COLITIS
Authors: HILLINGSO J KJELDSEN J LAURITSEN K VONSPRECKELSEN S DEPRE M FRIEDMAN BS MALMSTROM K SHINGO S BUKHAVE K RASKMADSEN J
Citation: J. Hillingso et al., BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE ORAL DOSE OF MK-0591 IN ACTIVE ULCERATIVE-COLITIS, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 335-341
SELECTIVE 5-LIPOXYGENASE INHIBITION BY ZILEUTON IN THE TREATMENT OF RELAPSING ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL
Authors: LAURSEN LS LAURITSEN K BUKHAVE K RASKMADSEN J JACOBSEN O NAESDAL J GOEBELL H PESKAR B RUBIN PD SWANSON LJ KESTERSON JW KESHAVARZIAN A KOZAREK R HANAUER S CORT D STENSON WF
Citation: Ls. Laursen et al., SELECTIVE 5-LIPOXYGENASE INHIBITION BY ZILEUTON IN THE TREATMENT OF RELAPSING ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL, European journal of gastroenterology & hepatology, 6(3), 1994, pp. 209-215
INHIBITION OF EICOSANOID SYNTHESIS AND POTENTIAL THERAPEUTIC BENEFITSOF DUAL PATHWAY INHIBITION
Authors: LAURITSEN K LAURSEN LS KJELDSEN J BUKHAVE K RASKMADSEN J
Citation: K. Lauritsen et al., INHIBITION OF EICOSANOID SYNTHESIS AND POTENTIAL THERAPEUTIC BENEFITSOF DUAL PATHWAY INHIBITION, Pharmacology & toxicology, 75, 1994, pp. 9-13
CLINICAL-TRAINING - BACK TO THE FUTURE
Authors: RASKMADSEN J
Citation: J. Raskmadsen, CLINICAL-TRAINING - BACK TO THE FUTURE, Gut, 35(7), 1994, pp. 1008-1009
FAILURE OF TROPISETRON TO INHIBIT JEJUNAL WATER AND ELECTROLYTE SECRETION INDUCED BY 5-HYDROXYTRYPTAMINE IN HEALTHY-VOLUNTEERS
Authors: MUNCK LK ESKEROD O HANSEN MB BUKHAVE K RASKMADSEN J
Citation: Lk. Munck et al., FAILURE OF TROPISETRON TO INHIBIT JEJUNAL WATER AND ELECTROLYTE SECRETION INDUCED BY 5-HYDROXYTRYPTAMINE IN HEALTHY-VOLUNTEERS, Gut, 35(5), 1994, pp. 637-640
Risultati: 1-25 | 26-30